These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 3157422

  • 1. Dopamine D2 receptor agents, but not dopamine D1, modify brain glucose metabolism.
    Palacios JM, Wiederhold KH.
    Brain Res; 1985 Feb 18; 327(1-2):390-4. PubMed ID: 3157422
    [Abstract] [Full Text] [Related]

  • 2. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA, Callahan PM, Appel JB.
    Eur J Pharmacol; 1985 Dec 10; 119(1-2):121-5. PubMed ID: 2935415
    [Abstract] [Full Text] [Related]

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 10; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS, Robertson HA.
    Brain Res; 1986 Oct 08; 384(2):387-90. PubMed ID: 2946360
    [Abstract] [Full Text] [Related]

  • 7. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 08; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 8. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
    Boyar WC, Altar CA.
    J Neurochem; 1987 Mar 08; 48(3):824-31. PubMed ID: 2949060
    [Abstract] [Full Text] [Related]

  • 9. Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
    Menon MK, Gordon LI, Kodama CK, Fitten J.
    Life Sci; 1988 Mar 08; 43(10):871-81. PubMed ID: 2901020
    [Abstract] [Full Text] [Related]

  • 10. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G, Demenge P.
    J Cardiovasc Pharmacol; 1991 Oct 08; 18(4):548-55. PubMed ID: 1724532
    [Abstract] [Full Text] [Related]

  • 11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 08; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 12. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM, Sheridan RD, Szabadi E.
    Br J Pharmacol; 1985 Oct 08; 86(2):483-90. PubMed ID: 2932196
    [Abstract] [Full Text] [Related]

  • 13. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions.
    Trugman JM, Wooten GF.
    J Neurosci; 1987 Sep 08; 7(9):2927-35. PubMed ID: 3114439
    [Abstract] [Full Text] [Related]

  • 14. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 08; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 15. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Kamijo N, Nagao T, Ono H.
    Neuropharmacology; 1993 Aug 08; 32(8):777-83. PubMed ID: 8105410
    [Abstract] [Full Text] [Related]

  • 16. Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes.
    Saller CF, Kreamer LD.
    Brain Res; 1991 Apr 19; 546(2):235-40. PubMed ID: 1829974
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists.
    Nunes JL, Sharif NA, Michel AD, Whiting RL.
    Neurochem Res; 1991 Oct 19; 16(10):1167-74. PubMed ID: 1686637
    [Abstract] [Full Text] [Related]

  • 18. Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.
    Mazurski EJ, Beninger RJ.
    Psychopharmacology (Berl); 1991 Oct 19; 105(1):107-12. PubMed ID: 1684056
    [Abstract] [Full Text] [Related]

  • 19. Dopamine receptor subtypes and formalin test analgesia.
    Morgan MJ, Franklin KB.
    Pharmacol Biochem Behav; 1991 Oct 19; 40(2):317-22. PubMed ID: 1687167
    [Abstract] [Full Text] [Related]

  • 20. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
    Morelli M, Fenu S, Di Chiara G.
    Life Sci; 1987 Jan 19; 40(3):245-51. PubMed ID: 2948094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.